Article Details

Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 ... - PR Newswire

Retrieved on: 2022-05-14 16:07:34

Tags for this article:

Click the tags to see associated articles and topics

Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 ... - PR Newswire. View article details on hiswai:

Excerpt

... with the proprietary platform technology developed by Baili and SystImmune. ... With multiple in-house proprietary platforms for innovative ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up